Patent · US Active

Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof

US11390609B2 · kind B2 · utility

1Cited by

3References

28Claims

0Family size

Assignee

BEIJING TIDE PHARMACEUTICAL CO., LTD. · CN

Inventors

Yanping Zhao · Beijing, CN
Hongjun Wang · Ningbo City, CN
Gong Li · Beijing, CN
Yuanyuan Jiang · Beijing, CN
Xiang Li · Beijing, CN
Bin Liu · Fishers, US
Weiting Zhong · Beijing, CN
Kai Liu · Beijing, CN
Fajie LI · Beijing, CN
Liying ZHOU · Beijing, CN
Yanan Liu · Beijing, CN

Key dates

Filing date	Jun 29, 2018
Grant date	Jul 19, 2022
Priority date	—
Expiry date	Oct 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/65583
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a Rho-associated protein kinase inhibitor of formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and a use of the same in preventing or treating a disease mediated by Rho-associated protein kinase (ROCK).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.